Pharmacokinetic (PK) profile of quisinostat in combination with gemcitabine and cisplatin in patients (pts) with non-small cell lung cancer (NSCLC) or paclitaxel and carboplatin in pts with NSCLC or epithelial ovarian cancer. (February 2017) - Fedyanin, M.; Tjulandin, S.; Cheporov, S.; Vladimirov, V.; Moiseenko, V.; Orlov, S.; Manikhas, G.; Koryakova, A.; Cakana, A.; Phelps, C.; Baranovsky, S.; Azarova, V.; et al.